InvestorsHub Logo
Followers 0
Posts 960
Boards Moderated 0
Alias Born 04/05/2009

Re: None

Tuesday, 09/17/2013 12:08:11 PM

Tuesday, September 17, 2013 12:08:11 PM

Post# of 1041
http://www.globalbiotechcorp.com/

http://www.pharmateck.com

is out

www.kraxispharma.com

is in.

But:

www.purthanol.com

"... Global Biotech Corporation has acquired the assets of the PURTHANOL consortium and soon will be changing its name to PURTHANOL. ..."

So the rest from Global like this:

http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9486268
29.8.2013
"...
GLOBAL’s goal is to position AquaBoost(TM), the bottled oxygenated water product it acquired, as an energizing alternative to soft drinks and as a beverage with more health benefits than ordinary water. To date, the aforementioned product has had minimal sales and the Company will endeavor, but can offer no guarantees, to raise its sales level significantly. Officers and director of the firm have committed to fund the operations of the Company until sufficient funds have been generated from ongoing business.
In an effort to expand its product line, the Company is working on developing a new product that we currently refer to as “Aquaboost-VitA: Orange Antioxidant”. This experimental product contains water oxygenated using the Aquaboost ™ technology, vitamin C, vitamin E and apple skin extract. The Company is in the research and testing phase of the product’s development, and is conducting research into the product’s antioxidant effects and palatability.
The Company’s short-term and medium-term objectives are as follows:
To attach our oxygenation unit in Quebec to the bottling line of a recognized North American bottler via a joint venture, said objective having been done.
To create a revenue stream through sales from strategic merchandising relationships and highly targeted markets - to this end, the Company is working on forming business relationships with pharmacy chains to place its nutraceutical beverage products in the next 6 to 12 months;
To strengthen its investor relations program, to increase shareholder value and increase public investors’ interest in the Company; and
To complete development of additional oxygenated and non-oxygenated drinks with nutraceutical values, which can be added to the Company’s product offering, distributed by others, or licensed to others.
...
and:
...
The Company entered, on October 31, 2010, into an agreement to purchase the rights to a nutraceutical product, specifically a topical cream for women, for a period of 4 years. The total cost of said agreement was $199,467. The Company is working on marketing this product towards the end of 2013.
..."

we will see soon below TRDX???

May be so or not. It is exciting!!